JPRN-UMIN000023593已完成未知
se of FreeStyle Libre Flash Glucose Monitoring System and the Effect on Hypoglycaemia in People with Type 2 Diabetes in Japan - SHIFT - Study of Hypoglycaemia using FreeStyle Libre
Abbott Diabetes Care Ltd0 个研究点目标入组 95 人开始时间: 2016年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 95
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Insulin regimen consists entirely of basal or bi-phasic insulin. Subject is currently prescribed animal insulin. Subject is currently prescribed oral, intra-articular, intramuscular or intravenous steroid therapy for any acute or chronic condition or requires it during the study period. Known (or suspected) allergy to medical grade adhesives. Currently participating in another device trial or drug study that could affect glucose measurements or glucose management. Currently using a Continuous Glucose Monitoring (CGM) device or FreeStyle Libre or has used one within the previous 4 months. Is planning to use a CGM device at any time during the trial. Total daily dose (TDD) of insulin >1.75 iu/kg at enrolment. Currently receiving dialysis treatment or planning to receive dialysis during the trial. Has experienced an acute myocardial infarction within previous 6 months. Has a concomitant disease or condition that may compromise patient safety, including and not limited to; unstable coronary heart disease, cystic fibrosis, severe mental illness, known or suspected eating disorder or any other uncontrolled long term medical condition. Has a pacemaker or any other neurostimulators. A female subject who is pregnant or planning to become pregnant within the trial duration. In the investigator's opinion, the subject is unsuitable to participate due to any other cause/reason.
研究者
相似试验
尚未招募
4 期
Performance of the Free Style Libre Flash Monitor versus laboratory method and the AccuChek during general anesthesia10018424Diabetes MellitusNL-OMON46217Isala Klinieken15
进行中（未招募）
1 期
A study to investigate the safety of the drugs topiramate and levetiracetamin treating children recently diagnosed with epilepsyew-onset or recent-onset epilepsy.MedDRA version: 20.0Level: PTClassification code 10015037Term: EpilepsySystem Organ Class: 10029205 - Nervous system disordersEUCTR2012-001552-19-ATJanssen-Cilag International N.V.63
进行中（未招募）
1 期
A study to investigate the safety of the drugs topiramate and levetiracetam in treating children recently diagnosed with epilepsyew-onset or recent-onset epilepsy.MedDRA version: 20.0Level: PTClassification code 10015037Term: EpilepsySystem Organ Class: 10029205 - Nervous system disordersEUCTR2012-001552-19-GBJanssen-Cilag International N.V.282
进行中（未招募）
1 期
A study to investigate the safety of the drugs topiramate and levetiracetam in treating children recently diagnosed with epilepsyew-onset or recent-onset epilepsy.MedDRA version: 20.0Level: PTClassification code 10015037Term: EpilepsySystem Organ Class: 10029205 - Nervous system disordersEUCTR2012-001552-19-DEJanssen-Cilag International N.V.282
进行中（未招募）
1 期
A study to investigate the safety of the drugs topiramate and levetiracetam in treating children recently diagnosed with epilepsyew-onset or recent-onset epilepsy.MedDRA version: 18.0Level: PTClassification code 10015037Term: EpilepsySystem Organ Class: 10029205 - Nervous system disordersEUCTR2012-001552-19-FRJanssen-Cilag International N.V.282